S. Mansueto

Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure.

F. Drago, G. Pignataro, A. Navarria, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network

L. Pani, S. Salomone, F. Drago, 2017, Clinical Drug Investigation.

Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies.

F. Drago, C. Bucolo, L. Gozzo, 2018, Journal of pharmacological sciences.

Beyond the budget silo approach: estimating health system sustainability for future dementia drugs

G. Trifirò, F. Caraci, F. Giorgianni, 2020 .

Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.

S. Salomone, F. Drago, A. Rotondo, 2018, Current drug safety.

Linking the Price of Cancer Drug Treatments to Their Clinical Value

A. Cicchetti, S. Salomone, F. Drago, 2016, Clinical Drug Investigation.

Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees

M. Ruggieri, T. Mattina, L. Malatino, 2021, BMC medical ethics.